NASDAQ:SDGR - Nasdaq - US80810D1037 - Common Stock - Currency: USD
22.64
-1.36 (-5.67%)
The current stock price of SDGR is 22.64 USD. In the past month the price decreased by -7.25%. In the past year, price decreased by -25.72%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 36.13 | 36.66B | ||
DOCS | DOXIMITY INC-CLASS A | 56.54 | 13.58B | ||
WAY | WAYSTAR HOLDING CORP | N/A | 7.26B | ||
CERT | CERTARA INC | 33.77 | 2.12B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.98B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 15.03 | 1.83B | ||
PHR | PHREESIA INC | N/A | 1.64B | ||
EVH | EVOLENT HEALTH INC - A | 15.8 | 1.22B | ||
HSTM | HEALTHSTREAM INC | 50.58 | 999.88M | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 966.46M | ||
DH | DEFINITIVE HEALTHCARE CORP | 14.47 | 762.50M | ||
SLP | SIMULATIONS PLUS INC | 79.43 | 638.26M |
Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. The company is headquartered in New York City, New York and currently employs 867 full-time employees. The company went IPO on 2020-02-06. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. The firm operates through two segments: Software and Drug Discovery. The Software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment is focused on building a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The firm's pipeline of drug discovery programs includes SGR-1505 (MALT1 Inhibitor), SGR-2921 (CDC7 Inhibitor), SGR-3515 (WEE1 Inhibitor). Its software was used by researchers around the world at more than 1,760 academic institutions.
SCHRODINGER INC
1540 Broadway, 24th Floor
New York City NEW YORK 10036 US
CEO: Ramy Farid
Employees: 867
Company Website: https://www.schrodinger.com
Investor Relations: https://ir.schrodinger.com/
Phone: 15032991150
The current stock price of SDGR is 22.64 USD. The price decreased by -5.67% in the last trading session.
The exchange symbol of SCHRODINGER INC is SDGR and it is listed on the Nasdaq exchange.
SDGR stock is listed on the Nasdaq exchange.
17 analysts have analysed SDGR and the average price target is 32.83 USD. This implies a price increase of 44.99% is expected in the next year compared to the current price of 22.64. Check the SCHRODINGER INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SCHRODINGER INC (SDGR) has a market capitalization of 1.65B USD. This makes SDGR a Small Cap stock.
SCHRODINGER INC (SDGR) currently has 867 employees.
SCHRODINGER INC (SDGR) has a support level at 22.63 and a resistance level at 25.67. Check the full technical report for a detailed analysis of SDGR support and resistance levels.
The Revenue of SCHRODINGER INC (SDGR) is expected to decline by -8.57% in the next year. Check the estimates tab for more information on the SDGR EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SDGR does not pay a dividend.
SCHRODINGER INC (SDGR) will report earnings on 2025-02-26, after the market close.
SCHRODINGER INC (SDGR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.43).
The outstanding short interest for SCHRODINGER INC (SDGR) is 16.09% of its float. Check the ownership tab for more information on the SDGR short interest.
ChartMill assigns a technical rating of 5 / 10 to SDGR. When comparing the yearly performance of all stocks, SDGR is a bad performer in the overall market: 75.69% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to SDGR. No worries on liquidiy or solvency for SDGR as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months SDGR reported a non-GAAP Earnings per Share(EPS) of -2.43. The EPS decreased by -526.32% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -26.53% | ||
ROE | -39.51% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 81% to SDGR. The Buy consensus is the average rating of analysts ratings from 17 analysts.
For the next year, analysts expect an EPS growth of -554.09% and a revenue growth -8.57% for SDGR